acyl-ghrelin: Clinical Trials

5 trials of acyl-ghrelin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 3 Not applicable, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Completed 1
Early Phase 11Completed 1
Phase 11Unknown 1

Follow acyl-ghrelin: new trials by email Literature Review of acyl-ghrelin trials Research Report on acyl-ghrelin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Ghrelin Administration on Motivation
Ghrelin, Saline - Major Depressive Disorder
Not applicableCompletedUniversity Hospital Tuebingen242024-09-022025-12-22
The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers
Acyl-Ghrelin - Renal Tubular Transport
Phase 1UnknownErling Bjerregaard Pedersen152015-05-012015-08-19
Ghrelin Effect on Beta Cell Function in Health and Disease
Exendin (9-39), acyl ghrelin, saline - Diabetes
Not applicableUnknownDavid Dalessio302013-04-012013-04-04
Local Metabolic Effects of Ghrelin in Skeletal Muscle and Adipose Tissue
Acyl ghrelin, Placebo (Ringer acetate) - Healthy
Early Phase 1CompletedEsben Thyssen Vestergaard102012-06-012013-01-16
Deacylated Ghrelin and Beta Cell Function
unacylated ghrelin, acyl ghrelin, combined acyl and desacyl ghrelin - the Diabetic Process
Not applicableUnknownDavid Dalessio302011-02-012012-11-14

Conditions studied

Anhedonia (1)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)  ·  Insulin Resistance (1)

Sponsors

David Dalessio (2)  ·  Erling Bjerregaard Pedersen (1)  ·  Esben Thyssen Vestergaard (1)  ·  University Hospital Tuebingen (1)

Countries

Denmark (2)  ·  United States (2)  ·  Germany (1)

Top investigators

Erling B Pedersen (1)  ·  Esben T. Vestergaard, MD PhD (1)  ·  Jenny Tong, MD, MPH (1)  ·  Nils B Kroemer, PhD (1)

Results publications

PMID 23592479, PMID 30065032

NIH funding

2014 (1), R03DK089090 (1)